A detailed history of Mairs & Power Inc transactions in Johnson & Johnson stock. As of the latest transaction made, Mairs & Power Inc holds 1,116,680 shares of JNJ stock, worth $163 Million. This represents 1.72% of its overall portfolio holdings.

Number of Shares
1,116,680
Previous 1,181,725 5.5%
Holding current value
$163 Million
Previous $173 Million 4.78%
% of portfolio
1.72%
Previous 1.68%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$145.48 - $167.38 $9.46 Million - $10.9 Million
-65,045 Reduced 5.5%
1,116,680 $181 Million
Q2 2024

Aug 14, 2024

SELL
$144.38 - $157.78 $5.02 Million - $5.49 Million
-34,789 Reduced 2.86%
1,181,725 $173 Million
Q1 2024

May 15, 2024

SELL
$155.22 - $162.74 $7.47 Million - $7.84 Million
-48,153 Reduced 3.81%
1,216,514 $192 Million
Q4 2023

Feb 14, 2024

SELL
$145.6 - $158.88 $11.7 Million - $12.8 Million
-80,484 Reduced 5.98%
1,264,667 $198 Million
Q3 2023

Nov 14, 2023

SELL
$155.75 - $174.48 $9 Million - $10.1 Million
-57,764 Reduced 4.12%
1,345,151 $210 Million
Q2 2023

Aug 14, 2023

SELL
$154.35 - $166.11 $2.95 Million - $3.17 Million
-19,098 Reduced 1.34%
1,402,915 $232 Million
Q1 2023

May 15, 2023

SELL
$151.05 - $180.26 $532,300 - $635,236
-3,524 Reduced 0.25%
1,422,013 $220 Million
Q4 2022

Feb 14, 2023

SELL
$160.2 - $179.79 $3.23 Million - $3.62 Million
-20,148 Reduced 1.39%
1,425,537 $252 Million
Q3 2022

Nov 14, 2022

SELL
$161.33 - $179.52 $3.38 Million - $3.76 Million
-20,964 Reduced 1.43%
1,445,685 $236 Million
Q2 2022

Aug 15, 2022

SELL
$168.19 - $186.01 $14.9 Million - $16.4 Million
-88,419 Reduced 5.69%
1,466,649 $260 Million
Q1 2022

May 16, 2022

BUY
$158.14 - $179.59 $607,573 - $689,984
3,842 Added 0.25%
1,555,068 $276 Million
Q4 2021

Feb 14, 2022

BUY
$155.93 - $173.01 $605,320 - $671,624
3,882 Added 0.25%
1,551,226 $265 Million
Q3 2021

Nov 15, 2021

BUY
$161.5 - $179.47 $1.35 Million - $1.51 Million
8,389 Added 0.55%
1,547,344 $250 Million
Q2 2021

Aug 16, 2021

SELL
$159.48 - $171.07 $192,651 - $206,652
-1,208 Reduced 0.08%
1,538,955 $254 Million
Q1 2021

May 14, 2021

SELL
$153.07 - $170.48 $3.55 Million - $3.96 Million
-23,204 Reduced 1.48%
1,540,163 $253 Million
Q4 2020

Feb 16, 2021

SELL
$137.11 - $157.38 $2.56 Million - $2.94 Million
-18,704 Reduced 1.18%
1,563,367 $246 Million
Q3 2020

Nov 16, 2020

SELL
$140.38 - $153.83 $3.71 Million - $4.06 Million
-26,416 Reduced 1.64%
1,582,071 $236 Million
Q2 2020

Aug 14, 2020

SELL
$128.81 - $155.51 $18.2 Million - $22 Million
-141,234 Reduced 8.07%
1,608,487 $226 Million
Q1 2020

May 15, 2020

SELL
$111.14 - $153.99 $32.3 Million - $44.7 Million
-290,216 Reduced 14.23%
1,749,721 $229 Million
Q4 2019

Feb 14, 2020

BUY
$127.5 - $146.44 $1.34 Million - $1.53 Million
10,479 Added 0.52%
2,039,937 $298 Million
Q3 2019

Nov 14, 2019

SELL
$126.95 - $142.14 $4.48 Million - $5.01 Million
-35,271 Reduced 1.71%
2,029,458 $263 Million
Q2 2019

Aug 14, 2019

SELL
$131.15 - $144.24 $1.47 Million - $1.62 Million
-11,201 Reduced 0.54%
2,064,729 $288 Million
Q1 2019

May 15, 2019

SELL
$125.72 - $139.79 $4.46 Million - $4.96 Million
-35,509 Reduced 1.68%
2,075,930 $290 Million
Q4 2018

Feb 14, 2019

SELL
$122.84 - $147.84 $3.55 Million - $4.28 Million
-28,930 Reduced 1.35%
2,111,439 $272 Million
Q3 2018

Nov 14, 2018

SELL
$121.58 - $142.88 $8.12 Million - $9.55 Million
-66,817 Reduced 3.03%
2,140,369 $296 Million
Q2 2018

Aug 14, 2018

SELL
$119.4 - $131.76 $1.73 Million - $1.91 Million
-14,510 Reduced 0.65%
2,207,186 $268 Million
Q1 2018

May 15, 2018

BUY
$125.1 - $148.14 $3.74 Million - $4.43 Million
29,877 Added 1.36%
2,221,696 $285 Million
Q4 2017

Feb 14, 2018

SELL
$131.22 - $143.62 $2.31 Million - $2.53 Million
-17,584 Reduced 0.8%
2,191,819 $306 Million
Q3 2017

Nov 14, 2017

BUY
$129.47 - $135.38 $286 Million - $299 Million
2,209,403
2,209,403 $287 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $381B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Mairs & Power Inc Portfolio

Follow Mairs & Power Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mairs & Power Inc, based on Form 13F filings with the SEC.

News

Stay updated on Mairs & Power Inc with notifications on news.